For decades, diagnosing Parkinson’s disease has been a challenge, often requiring clinical evaluations, DaT SPECT scans, and ...

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement ...

A GROUNDBREAKING study has identified rare genetic variants in the ITSN1 gene that increase Parkinson’s disease risk by up to tenfold and reveal unexpected links to autism spectrum disorder (ASD), ...

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five ...

CYP46A1 knockdown relieves the spread of α-Syn pathology and the loss of dopaminergic ... in the progression of α-synuclein pathology in Parkinson’s disease, highlighting its potential as ...

the authors link FAM171A2 to α-synuclein pathology.” The authors next investigated if FAM171A2 protein levels are altered in PD. In cerebrospinal fluid samples from 30 people with PD and an equal ...

Existing research indicates that the accuracy of a Parkinson’s disease diagnosis hovers between 55% and 78% in the first five years of assessment. That’s partly because Parkinson’s sibling movement ...

This dual action—targeting both protein aggregation and mitochondrial dysfunction—positions TFE3 as a promising therapeutic candidate for Parkinson's disease. By bolstering the brain's natural ...

This recent study highlights the neuroprotective potential of TFE3, a transcription factor that plays a pivotal role in counteracting key pathological mechanisms associated with Parkinson's disease ...

WEHI researchers have made a huge leap forward in the fight against Parkinson’s disease, solving a decades-long mystery that paves the way for development of new drugs to treat the condition.